In an orthotopic mouse model of Lewis lung carcinoma (LLC), cell therapy with reprogrammed CD8+ T-cells isolated from mouse bone marrow demonstrated strong antitumor effects [15]. The gene discussed is CD8A; the disease is Carcinoma, Lewis Lung.